Get started
Author

Helen C. Thorne

Observed names: H. Thorne, H., Thorne, Helen C THORNE, Helen C Thorne, Helen Thorne, Thorne, H.
ORCID: 0000-0002-6422-4623
Observed ORCID: 0000-0002-6422-4623
OpenAlex ID: A5016547253
The spectral composition of evening light and individual differences in the suppression of melatonin and delay of sleep in humans
2011 · Nayantara Santhi, Helen C. Thorne, et al. · Journal of Pineal Research · 229
Daily and Seasonal Variation in the Spectral Composition of Light Exposure in Humans
2009 · Helen C. Thorne, Kay H. Jones, et al. · Chronobiology International · 164
Differences in Sleep, Light, and Circadian Phase in Offshore 18:00–06:00 h and 19:00–07:00 h Shift Workers
2008 · Helen Thorne, Shelagh Hampton, et al. · Chronobiology International · 41
Patient Preference and Physician Perceptions of Patient Preference for Oral Pharmaceutical Formulations: Results from a Real-Life Survey
2018 · Lara MacKenzie-Smith, Paolo Marchi, et al. · Inflammatory Intestinal Diseases · 26
Returning from night shift to day life: Beneficial effects of light on sleep
2010 · Helen C THORNE, Shelagh M HAMPTON, et al. · Sleep and Biological Rhythms · 26
Targeted colonic release formulations of mesalazine – A clinical pharmaco-scintigraphic proof-of-concept study in healthy subjects and patients with mildly active ulcerative colitis
2022 · F. Varum, H. Thorne, et al. · International Journal of Pharmaceutics · 21
PDF
Medication Formulation Preference of Mild and Moderate Ulcerative Colitis Patients: a European Survey
2023 · Xavier Hébuterne, Stephan R Vavricka, et al. · Inflammatory Intestinal Diseases · 7
Assessing the Clinical and Endoscopic Efficacy of Extended Treatment Duration with Different Doses of Mesalazine for Mild-to-Moderate Ulcerative Colitis beyond 8 Weeks of Induction
2023 · Geert D'Haens, Ekaterina Safroneeva, et al. · Inflammatory Intestinal Diseases · 6
Comparative Efficacy of Mesalazine and Ozanimod following Induction Treatment in Mesalazine-Exposed Advanced Therapy-Naïve Adult Ulcerative Colitis Patients
2025 · Geert D'Haens, Ekaterina Safroneeva, et al. · Inflammatory Intestinal Diseases
PDF
The Impact of Mesalazine Pill Burden on Compliance in Inflammatory Bowel Disease Patients
2025 · Julien Kirchgesner, Helen Thorne, et al. · Inflammatory Intestinal Diseases
PDF
Similar Efficacy of Mesalazine in Adult and Older Adult Ulcerative Colitis Patients: Post Hoc Analysis of a Randomized Noninferiority Trial of 1600 mg vs 400 mg Tablets
2024 · Ekaterina Safroneeva, Helen Thorne, et al. · Inflammatory Bowel Diseases
Supplementary Material for: Assessing the clinical and endoscopic efficacy of extended duration treatment with different doses of mesalazine for mild to moderate ulcerative colitis beyond 8 weeks of induction
2023 · G., D'Haens, E., Safroneeva, et al. · Figshare
Supplementary Material for: Patient Preference and Physician Perceptions of Patient Preference for Oral Pharmaceutical Formulations: Results from a Real-Life Survey
2018 · MacKenzie-Smith, L., Marchi, P., et al. · Figshare
Works count: 15
Citation count: 520
H-index: 7
I10-index: 6
Year
Topic
Type